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Cell wall-associated (CWA) proteins made by Gram-positive pathogens play a fundamental role in patho-
genesis. Staphylococcus pseudintermedius is a major animal pathogen responsible for the canine skin disease
bacterial pyoderma. Here, we describe the bioinformatic analysis of the family of 18 predicted CWA proteins
encoded in the genome of S. pseudintermedius strain ED99 and determine their distribution among a phylo-
genetically diverse panel of S. pseudintermedius clinical isolates and closely related species of the Staphylococcus
intermedius group. In parallel, we employed a proteomic approach to identify proteins presented on the surface
of strain ED99 in vitro, revealing a total of 60 surface-localized proteins in one or more phases of growth,
including 6 of the 18 genome-predicted CWA proteins. Based on these analyses, we selected two CWA proteins
(SpsD and SpsL) encoded by all strains examined and investigated their capacity to mediate adherence to
extracellular matrix proteins. We discovered that SpsD and SpsL mediated binding of a heterologous host,
Lactococcus lactis, to fibrinogen and fibronectin and that SpsD mediated binding to cytokeratin 10, a major
constituent of mammalian skin. Of note, the interaction with fibrinogen was host-species dependent, suggestive
of a role for SpsD and SpsL in the host tropism of S. pseudintermedius. Finally, we identified IgG specific for
SpsD and SpsL in sera from dogs with bacterial pyoderma, implying that both proteins are expressed during
infection. The combined genomic and proteomic approach employed in the current study has revealed novel
host-pathogen interactions which represent candidate therapeutic targets for the control of bacterial
pyoderma.
Skin diseases are a major cause of morbidity in dogs and an
important animal welfare issue (33, 42). In particular, bacterial
pyoderma caused by Staphylococcus pseudintermedius (for-
merly regarded as Staphylococcus intermedius [2]) is one of the
most common diseases seen in small-animal veterinary prac-
tice worldwide (21). Although this organism is now regarded as
a resident of the nares and perianal areas (33), disruption of
the normal skin flora (e.g., by inappropriate antibacterial ther-
apy), damage to the cutaneous barrier by a pruritic condition
(e.g., hypersensitivities), immunosuppression by a systemic dis-
ease (e.g., hypothyroidism and hyperadrenocorticism), or pri-
mary immunodeficiencies (e.g., selective IgA deficiency) can
lead to surface, superficial, or deep pyodermas caused by this
nomadic organism (42). Treatment of canine pyoderma is of-
ten difficult without resorting to aggressive, medium-term ad-
ministration of systemic antibacterial agents to prevent relapse
of infection, and such therapy predisposes to the development
of bacterial resistance that may be transferred to bacteria in-
fecting humans (18). Of note, methicillin-resistant S. pseudin-
termedius has recently emerged as a major problem in veteri-
nary clinics worldwide (2, 34). Although rare, several episodes
of life-threatening infections of humans by S. pseudintermedius
have been reported, with the typical route of transmission
being through dog bite wounds (17, 36). Previously, crude
vaccine preparations based on Staphylococcus aureus phage
lysate or S. pseudintermedius autogenous bacterin have shown
promise as adjunctive therapies for treatment of pyoderma (7,
8), and a rationally designed effective vaccine would be a highly
desirable means to reducing the suffering associated with the
disease.
Recent studies of cell wall-associated (CWA) proteins of the
human and animal pathogen S. aureus indicate that some
CWA proteins represent promising targets for immunothera-
peutic and vaccine design (14, 49). However, our knowledge of
the diversity and function of surface-presented proteins of S.
pseudintermedius is very limited. Recent reports demonstrated
that S. pseudintermedius has several host protein-binding prop-
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erties in common with S. aureus, including the ability to bind to
the extracellular matrix (ECM) proteins fibrinogen, fibronec-
tin, and cytokeratin (15, 40). In addition, we along with others
have demonstrated that S. pseudintermedius attaches to epider-
mal cells of healthy and atopic dogs (12, 29, 44, 45). However,
the bacterial determinants responsible for these interactions
have not been identified.
In order to provide a framework for investigating the patho-
genesis of S. pseudintermedius and to identify new targets for
the design of disease intervention strategies, we recently se-
quenced the whole genome of a clinical isolate of S. pseudin-
termedius (strain ED99) from a case of canine pyoderma, re-
vealing the complement of encoded putative virulence factors
(3). In the current study, we describe the family of CWA
proteins encoded by S. pseudintermedius and their distribution
among clinical isolates and closely related species of the S.
intermedius group. In parallel, we identify the complement of
proteins presented on the S. pseudintermedius ED99 cell sur-
face during growth in vitro. Finally, we identify specific CWA
proteins expressed by S. pseudintermedius during canine infec-
tion which mediate binding to the ECM proteins fibrinogen,
fibronectin, and cytokeratin 10, suggesting an important role in
disease pathogenesis.
MATERIALS AND METHODS
Bacterial strains and growth conditions. S. pseudintermedius strain ED99 was
isolated from a dog with bacterial pyoderma presented to the Dermatology
Service of The Hospital for Small Animals, The Royal (Dick) School of Veter-
inary Studies [R(D)SVS], The University of Edinburgh (2, 45). Phylogenetically
diverse clinical isolates of S. pseudintermedius, Staphylococcus delphini, and S.
intermedius used for CWA gene screening were selected to represent the diver-
sity identified in a previous population genetic study of the S. intermedius group
(SIG) (2). The study had employed concatenated sequences specific for five core
genome loci, including the 16S rRNA, cpn60 (hsp60), tuf, pta, and agrD genes, to
examine the genetic diversity among strains phenotypically identified as SIG
members (2). S. aureus strain SH1000 (22), S. aureus strain Newman, a Newman
clfA strain (deficient in ClfA expression) (11), and Lactococcus lactis expressing
FnbpA, encoded by plasmid pKS80 (27), were used as controls for binding to
fibrinogen, fibronectin, and cytokeratin 10. L. lactis constructs expressing CWA
proteins of S. pseudintermedius ED99 were generated using L. lactis subspecies
cremoris strain MG1363 and expression plasmid pOri23 (37). S. aureus strains
were grown to stationary phase overnight or to exponential phase (optical density
at 600 nm [OD600] of 0.5 to 0.8) at 37°C in tryptic soy broth (TSB) with shaking.
L. lactis bacterial cultures were grown statically at 30°C overnight in GM17 broth.
In silico structural analysis of cell wall-anchored proteins. The complete
genome sequence of S. pseudintermedius strain ED99 was deposited in the
GenBank database under the accession number CP002478. The predicted CWA
proteins were examined for functional domains using EMBL-EBI InterPro Scan
(http://www.ebi.ac.uk/interpro). Structural analysis was carried out with the
PHYRE (Protein Homology/analogY Recognition Engine) fold recognition
server, available from the Structural Bioinformatics Group, Imperial College
London, London, United Kingdom (http://www.sbg.bio.ic.ac.uk/phyre/). Repeat
sequences were predicted by generating nucleic acid dot plots, using software
available from Colorado State University (http://www.vivo.colostate.edu/molkit
/dnadot/), applying tandem repeat finder software from Boston University (http:
//tandem.bu.edu/trf/trf.html) and variable sequence tandem repeat extraction
and architecture modeling (XSTREAM), available from the University of Cal-
ifornia (http://jimcooperlab.mcdb.ucsb.edu/xstream/). Sequence alignments and
pairwise sequence comparisons were generated with Clustal W2 (http://www.ebi
.ac.uk/Tools/clustalw2). Amino acid composition and molecular weight predic-
tions were generated using ProtParam on the ExPASy Proteomics Server (http:
//www.expasy.ch/tools/protparam.html).
Southern blot analysis. Genomic DNA was extracted using a PerElute
genomic DNA isolation kit (Edge Biosystems) as previously described (2), re-
striction digested with HindIII restriction endonuclease (New England BioLabs,
United Kingdom), resolved by agarose electrophoresis, and transferred to nylon
membranes as per the method of Southern (47). Probes were designed using
oligonucleotides designed to amplify 500-bp regions specific for each gene
encoding putative CWA proteins (Table 1) and were labeled using a Direct
Nucleic Acid Labeling and Detection System (Amersham BioSciences, GE
Healthcare, United Kingdom).
Tryptic digestion and processing of bacterial surface proteins. An overnight
culture of S. pseudintermedius ED99 was inoculated into 50 ml of brain heart
infusion (BHI) broth to an OD600 of 0.04 and was grown to an early exponential
(OD600 of 0.2), mid-exponential (OD600 of 0.5), or late exponential (OD600 of
0.65) phase of growth. Cells were harvested by centrifugation at 4,500  g for 10
min and washed twice in ice-cold phosphate-buffered saline (PBS), followed by
resuspension in 0.5 ml of PBS containing 40% (wt/vol) sucrose. Digestion was
carried out with 20 g of trypsin (Promega, United Kingdom) in the presence of
5 mM dithiothreitol (DTT; Millipore) for 2 h at 37°C with gentle shaking. The
digestion mixture was centrifuged at 4,500  g for 10 min, and the supernatant
was incubated overnight at 37°C, followed by passage through a 4-mm by
0.45-m Millex-HV polyvinylidene difluoride (PVDF) membrane filtration unit
(Millipore) to remove microparticulates. Filtered digests (0.5 ml) were injected
directly onto a 250-mm by 4.6-mm Jupiter 5U, C5, 300-Å reversed-phase column
(Phenomenex) equilibrated with 2% acetonitrile and 0.1% (wt/vol) trifluoro-
acetic acid (TFA) at a flow rate of 0.5 ml/min. UV absorbance at 214 nm was
monitored until the reading stabilized at baseline level. Bound material was
eluted for 5 min by applying a linear gradient of 2% to 80% acetonitrile–0.1%
(wt/vol) TFA, and fractions of 1 ml were collected every 2 min for 30 min.
LC-ESI-MS/MS. High-performance liquid chromatography (HPLC) fractions
corresponding to peaks of UV-absorbent material were frozen at 70°C before
lyophilization overnight in a ModlyoD freeze dryer (Thermo Electron Corpora-
tion) in accordance with the manufacturer’s recommendations. Lyophilized res-
idues were each reconstituted in a total of 100 l per digest of HPLC-grade water
(Rathburn Chemicals, Ltd). Each reconstituted sample was passed through a
second 4-mm by 0.45-m Millex-HV PVDF membrane filtration unit to remove
any insoluble material and microparticulates. Filtered samples were transferred
to HPLC sample vials and stored at 4°C until required for liquid chromatogra-
phy-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) analy-
sis. Liquid chromatography was performed using an Ultimate 3000 nano-HPLC
system (Dionex) consisting of a WPS-3000 well plate micro autosampler, an
FLM-3000 flow manager and column compartment, a UVD-3000 UV detector,
an LPG-3600 dual-gradient micropump, and an SRD-3600 solvent rack con-
trolled by Chromeleon chromatography software (Dionex). A micropump flow
rate of 246 l/min was used in combination with a cap-flow splitter cartridge,
affording a 1/82 flow split and a final flow rate of 3 l/min through a 5-cm by
200-m (internal diameter) monolithic reversed-phase column (Dionex-LC
Packings) maintained at 50°C. Samples of 1 to 4 l were applied to the column
by direct injection, and peptides were eluted by the application of a 15-min linear
gradient from 8% to 45% solvent B (80% acetonitrile, 0.1% [vol/vol] formic
acid), directed through a 3-nl UV detector flow cell. LC was interfaced directly
with a three dimensional (3D) high-capacity ion trap mass spectrometer (Esquire
HCTplus; Bruker Daltonics) via a low-volume (50 l/min maximum) stainless
steel nebulizer (catalog number G1946-20260; Agilent) and ESI. Parameters for
tandem MS analysis were set as previously described (2a).
Database mining. Deconvoluted MS/MS data were submitted to an in-house
MASCOT server and searched against a specific and fully annotated S. pseud-
intermedius strain ED99 genome sequence using the MASCOT search algorithm
(Matrix Science). The presentation and interpretation of MS/MS data were
performed in accordance with published guidelines (51). To this end, fixed and
variable modifications selected were carbamidomethyl (C) and oxidation (M),
respectively, and mass tolerance values for MS and MS/MS were set at 1.5 Da
and 0.5 Da, respectively. Molecular weight search (MOWSE) scores attained for
individual protein identifications were inspected manually and considered sig-
nificant only if (i) two peptides were matched for each protein and (ii) each
peptide contained an unbroken b or y ion series of a minimum of 4 amino acid
residues.
Expression of S. pseudintermedius CWA proteins in L. lactis MG1363. PCR
amplification of the full-length spsD and spsL genes was carried out with oligo-
nucleotides which included PstI, SalI, or BamHI restriction sites to facilitate
cloning (Table 1). PCR mixtures of 50 l contained 0.25 M forward and reverse
primers, 1 Pfu Ultra II reaction buffer (Stratagene), 0.25 mM (each) deoxy-
nucleoside triphosphate (dNTP; Promega), 5 U of Pfu Ultra II Fusion HS DNA
polymerase (Stratagene), and approximately 100 ng of genomic DNA template.
The thermocycler program included an initial denaturation step at 95°C for 2
min, followed by 30 cycles of 95°C for 20 s, 50°C for 20 s, and 72°C for 2 min, with
a final incubation at 72°C for 3 min. PCR products were visualized on 0.8%
(wt/vol) agarose gels and purified using a QIAquick Gel Extraction Kit (Qiagen,
United Kingdom) according to the manufacturer’s instructions. Purified DNA
VOL. 79, 2011 STAPHYLOCOCCUS PSEUDINTERMEDIUS SURFACE PROTEOME 3075
 o
n
 O
ctober 20, 2015 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
fragments were cloned into the StrataClone Blunt PCR cloning vector pSC-B
(Stratagene) according to the manufacturer’s instructions. Vector inserts were
then subcloned into the Escherichia coli-L. lactis shuttle vector pOri23 using PstI,
SalI, or BamHI restriction enzyme (37) and transformed into electrocompetent
E. coli DH5 cells. CWA protein-encoding pOri23 constructs were purified using
a Qiagen MiniPrep Kit (Qiagen, United Kingdom) and transformed into elec-
trocompetent L. lactis cells, as described previously (37). L. lactis transformants
were screened by plasmid isolation using a Qiagen MiniPrep Kit (Qiagen, United
Kingdom) with addition of 100 U/ml mutanolysin (Sigma-Aldrich, United King-
dom) and 100 g/ml lysozyme (Sigma-Aldrich, United Kingdom) to buffer P1,
followed by diagnostic restriction digestion with appropriate restriction enzymes.
DNA sequencing of each gene insert was carried out to confirm the absence of
spurious mutations.
Cloning, expression, and purification of CWA A-domain peptides. To generate
recombinant proteins of the putative ligand-binding A domains of the predicted
CWA proteins SpsD and SpsL, Gateway recombination cloning technology was
employed (Invitrogen, United Kingdom). Oligonucleotides were designed for
PCR amplification of the region encoding the A domain of spsD and spsL which
included Gateway-compatible upstream and downstream nucleotide extensions
(Table 1), and cloning was carried out according to the manufacturer’s instruc-
tions. The destination vector (petG-K-NHis) based on a pET expression vector
conferring kanamycin resistance and encoding a His6 tag at the N terminus was
employed, and the expression construct was transformed into electrocompetent
E. coli BL21 cells.
For the purification of recombinant protein, 4 liters of E. coli BL21 exponen-
tial phase liquid cultures was induced by adding 0.2 mM isopropyl--d-thioga-
lactopyranoside (IPTG; Sigma-Aldrich) for 4 h at 37°C in a shaking incubator at
225 rpm. Bacterial cultures were centrifuged at 1,912  g for 10 min, pellets were
resuspended in 20 ml of nickel column buffer A (20 mM NaPO4, 0.5 M NaCl),
and bacterial cells were lysed using a French press (SLM Aminco; SLM Instru-
ments, Inc.). Samples were ultracentrifuged at 180,000  g at 4°C for 20 min and
filtered using a 0.45-m-pore-size filter device (Millipore). Proteins were purified
by applying the samples to nickel columns (Nickel HisTrap HP; GE Healthcare)
attached to a fast protein liquid chromatography (FPLC) machine (A¨KTA, GE
Healthcare) using nickel column buffer A and buffer B (20 mM NaPO4, 0.5 M
NaCl, 0.5 M imidazole). Samples were further purified using a Q Sepharose
column (HiTrap 5-ml QHP; GE Healthcare) attached to an FPLC machine
(A¨KTA, GE Healthcare) with Q Sepharose column buffer A (1 mM EDTA in
TABLE 1. Oligonucleotides employed during the study
Primer namea Sequence (5–3)b Purpose
spsD-F CATGGGATCCAGAGAAGAAGAGGGA L. lactis cloning
spsD-R GCACCTGCAGGGGTTTTTTAATGTG L. lactis cloning
spsL-F GTTATGAGTTAGTCGACAGGGAGTT L. lactis cloning
spsL-R GAAACTGCAGATATATTGACCAC L. lactis cloning
spsD-region A-Fc TCAGAAGTGAGCGCAACAACAC A domain cloning
spsD-region A-Rc ATTCCAGTTTTCTAACGGGAAGAAACCAGC A domain cloning
spsL-region A-Fc AATGAAGATGTCACTGAAACAACTGGGAG A domain cloning
spsL-region A-Rc CCATCCTATATCAATCACATGGC A domain cloning
spsA-F TTGGTAGTGGACTGCAAATGCC Southern probe
spsA-R GGTCTTTCAGTGCGCTCACATC Southern probe
spsB-F GCCTTGATTTCGGTGTCAGACA Southern probe
spsB-R GCTGCCACCTAGAACGATTGC Southern probe
spsC-F CACGCCACTCGGTTGGTTCA Southern probe
spsC-R TGGAATGCGCCATAGTACCAAG Southern probe
spsD-F TGGTCAAGGAGAATTGCCACA Southern probe
spsD-R TTTTCACCACGATCCTCACCA Southern probe
spsE-F AACGCGTCAAACAACGTGCAA Southern probe
spsE-R CGCCATCAGTCGAAACGTAGGA Southern probe
spsF-F AGTGGAAGCAACAGTTGAACGC Southern probe
spsF-R TGGACCTACTTGGCTACCACCA Southern probe
spsG-F AACACAGCTGACAAAGCAACCG Southern probe
spsG-R CGATGTTTGCAGTTTGGCATTT Southern probe
spsH-F GATCAAAGGGCACACATGGATG Southern probe
spsH-R CCGTTATCAGTGGCAGGTGGT Southern probe
spsI-F GCAAACAAAAAAGCACCTGCAC Southern probe
spsI-R AAGATTCGCCTGCAATGTCGTA Southern probe
spsJ-F GTACGTCGGTTTCATTGAGCCA Southern probe
spsJ-R TTGACACTGATGCCGAAGCAC Southern probe
spsK-F ATTTCACAAGGGAACGCACATG Southern probe
spsK-R TGAGCCGCACGTCTATTCTGAA Southern probe
spsL-F ATGGCAAGCAAAATTTGACTGC Southern probe
spsL-R GTGTCAGCTTGCGCATCATATG Southern probe
spsM-F GGTGCTAAAGCCTACGATGCG Southern probe
spsM-R CCTCAACAATACTGCCCGATGA Southern probe
spsN-F GTGGCAAGGTCGTTATGACGGG Southern probe
spsN-R TGCCCTGATCCTTGATGTTTTGT Southern probe
spsO-F GGTAGTGTATCAGTGCTAATAGGAGCC Southern probe
spsO-R TTGACAAATCAGTAGCTGATGCATC Southern probe
spsP-F CAGGAGGACTAGGGTAATGTTCC PCR detection
spsP-R GCAAAACTTGGCGTGTTTACAAG PCR detection
spsQ-F CCGCTCTATTTTTAGGTTAATC PCR detection
spsQ-R GCGCTTCATCGAAACTTGGCGCAGG PCR detection
spsR-F TGGTCTAGGGCTATTAGCAACA PCR detection
spsR-R TCAGATTCACCTGTGTTTGG PCR detection
a F, forward primer; R, reverse primer.
b Inserted restriction sites are underlined.
c Gateway specific nucleotides were added on each side of the DNA fragments (forward extension, 5-AAAAAGCAGGCTCCGCCATG-3; reverse extension,
5-AGAAAGCTGGGTC-3).
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PBS, pH 7.4) and Q Sepharose column buffer B (1 mM EDTA, 1 M NaCl in PBS,
pH 7.4). Samples were extensively dialyzed (Fisherbrand dialysis tubing with a
molecular weight cutoff of 12,000 to 14,000; Fisherbrand) against PBS at 4°C
after each column.
Western blot analysis of recombinant CWA-associated proteins. Protein sam-
ples were resolved by SDS-PAGE in 10% polyacrylamide gels, and Western blot
transfer onto Amersham Hybond ECL Nitrocellulose Membrane (GE Health-
care, United Kingdom) was carried out under standard conditions; the resulting
blot was blocked overnight in 5% (wt/vol) nonfat dried milk powder (Fluka) in
PBS at 4°C. One liter of Western transfer buffer contained 0.15 M glycine, 8.4
mM SDS, and 20% (vol/vol) methanol. The blocked membranes were incubated
with a 1:1,000 dilution of pooled serum samples from three canine bacterial
pyoderma cases obtained from patients of the Dermatology Service of The
Hospital for Small Animals, Division of Veterinary Clinical Sciences, The Royal
(Dick) School of Veterinary Studies, The University of Edinburgh) in 1% (wt/
vol) milk for 1 h at room temperature, followed by three washes with TBST
buffer (0.14 M NaCl, 2.7 mM KCl, 25 mM Tris base, 0.05% Tween 20, pH 7.5).
Secondary antibody incubation was carried out with a 1:3,000 dilution of horse-
radish peroxidase (HRP)-conjugated sheep anti-canine IgG (Bethyl Laborato-
ries, Inc.) for 1 h at room temperature, and bound antibodies were detected after
exposure to Amersham High Performance chemiluminescent film (GE Health-
care, United Kingdom).
Bacterial adherence assays. Bacterial adherence assays were carried out using
commercially available fibrinogen of canine, human, feline, and bovine origin
(Sigma-Aldrich, United Kingdom) and bovine fibronectin (Calbiochem, EMD
Biosciences). In addition, fibrinogen was purified from canine, equine, and avian
blood (Lampire) by modified cold ethanol fractionation according to previously
published protocols (6, 9). Recombinant cytokeratin 10 was expressed and pu-
rified from a pQE30 expression clone which encoded the C terminus of mouse
cytokeratin 10 (rMCK10 294-570) (54). Recombinant protein expression in E.
coli XL1-Blue cells (Stratagene, United Kingdom) was induced with IPTG (0.5
mM) and protein purified under hybrid conditions according to the manufactur-
er’s instructions using a Ni-nitrilotriacetic acid (NTA) benchtop purification
system (Invitrogen, United Kingdom). Solid-phase adherence assays with S.
pseudintermedius or L. lactis cells binding to fibrinogen, fibronectin, or cytoker-
atin 10 were carried out as described previously (11). Each assay was performed
in triplicate, and each experiment was repeated at least once, independently.
Statistical significance of adherence values at the 20 g/ml concentration, relative
to controls, was determined using a Student’s t test.
RESULTS AND DISCUSSION
S. pseudintermedius strain ED99 adheres to extracellular
matrix proteins. In order to investigate the capacity of S.
pseudintermedius strain ED99 to bind to the extracellular ma-
trix (ECM), we examined the adherence of exponential (OD600
of 0.5) and stationary phase cultures to doubling dilutions of
fibrinogen, fibronectin, and cytokeratin 10 in solid-phase assays
(Fig. 1). In the exponential phase of growth, S. pseudinterme-
dius ED99 demonstrated adherence to canine fibrinogen, bo-
vine fibronectin, and mouse cytokeratin 10 (P 	 0.01) (Fig. 1).
When grown to stationary phase of growth, S. pseudintermedius
ED99 adhered also to fibronectin (P 	 0.01) but did not
adhere to fibrinogen or cytokeratin 10 (Fig. 1). The variation in
adherence of S. pseudintermedius ED99 in exponential and
stationary phases of growth implies that some surface factors
mediating adherence to the extracellular matrix are expressed
in a growth phase-dependent manner. Of note, the previously
characterized S. pseudintermedius strain 326 exhibited similar
trends for the binding of fibronectin and cytokeratin 10 but, in
contrast to strain ED99, could bind to fibrinogen in the sta-
tionary phase of growth (15). These findings highlight strain-
dependent differences in the surface presentation of extracel-
lular matrix-binding proteins by S. pseudintermedius, as
observed previously (15). Overall, the data suggest that S.
pseudintermedius ED99 expresses surface components which
mediate binding to fibrinogen, fibronectin, and cytokeratin 10
and that these components are expressed in a growth phase-
dependent manner.
In silico analysis of the family of CWA proteins encoded by
S. pseudintermedius ED99. Analysis of the genome of strain
ED99 revealed 18 genes encoding putative CWA proteins with
a predicted minimum length of approximately 250 amino acids
(aa) which contained one or more sequence motifs typical of
CWA proteins, including an N terminus signal sequence, char-
acteristic repeat regions, and an LPXTG cell wall anchor motif
(named S. pseudintermedius surface protein; SpsA to SpsR)
FIG. 1. Adherence of S. pseudintermedius strain ED99 to immobi-
lized ligands. Plates were coated with doubling dilutions of fibrinogen
(A), fibronectin (B), and cytokeratin 10 (C) and incubated with S.
pseudintermedius ED99 grown to exponential (f) or stationary (F)
phase of growth. Absorbance was measured at 590 nm, and results are
expressed as mean values of triplicate samples; error bars indicate
standard deviations. S. aureus strain SH1000, strain Newman, and an
isogenic derivative of strain Newman deficient in ClfA production
were used as controls (data not shown).
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(Fig. 2). BLASTx analysis of the NCBI database resulted in
sequence identities with known staphylococcal proteins rang-
ing from 25% to 77% (Fig. 3). Signal sequences necessary for
Sec-dependent protein secretion (13) were predicted for 15
putative Sps proteins, but no obvious signal sequence was pre-
dicted for SpsE, SpsI, and SpsJ (Fig. 3).
Repeat regions are a common feature of staphylococcal
CWA proteins, such as the Sdr-family, members of which con-
tain a serine-aspartate dipeptide region (13). Accordingly, the
18 putative CWA proteins were examined for the presence of
tandem repeat regions, which were detected for SpsD, SpsF,
SpsI, SpsJ, SpsL, SpsO, SpsP, and SpsQ (Table 2 and Fig. 3).
Of note, SpsI contains repeats which belong to the B-repeat
superfamily, sharing 52% overall identity with the B repeats of
SdrD of S. aureus strain COL. None of the predicted repeats
are serine-aspartate, characteristic of proteins in the Sdr family
(13), but the repeat motifs of SpsO are serine rich, containing
578 serine residues (49.9% of the amino acid composition in
the repeat region). In addition, SpsJ contains mainly serine
(447 residues, or 49.9%), threonine (163 residues, or 18.2%),
and aspartate (113 residues, or 12.6%) residues, resulting in
conserved motifs SDSD and STS (Table 2). Repeat regions of
previously characterized staphylococcal CWA proteins such as
the fibronectin-binding protein A (FnbpA) have been shown to
be involved in ligand binding (41) but may also function as
molecular stalks which project the ligand-binding domain away
from the bacterial cell surface (19).
In staphylococcal CWA proteins, -sheet-rich IgG-like folds
of the A domain have been shown to be important for ligand
binding (35). Therefore, the putative CWA proteins identified
in the S. pseudintermedius ED99 genome were examined for
predicted IgG-like folds. Based on InterPro Scan and PHYRE
predictions, two IgG-like folds each were identified within the
nonrepeated A domains of SpsD, SpsI, SpsL, and SpsO (Fig.
3), dividing the A domains into N1, N2, and N3 subdomains.
The predicted locations of the IgG-like folds are residues 167
to 320 (N2) and 322 to 519 (N3) for SpsD, residues 220 to 363
(N2) and 364 to 531 (N3) for SpsL, residues 202 to 351 (N2)
and 347 to 512 (N3) for SpsI, and residues 339 to 492 (N2) and
487 to 659 (N3) for SpsO.
Of the 18 putative CWA proteins of S. pseudintermedius
ED99, SpsD, SpsL, and SpsO contained each of the
MSCRAMM (microbial surface components recognizing ad-
hesive matrix molecules) features screened for, including a
signal sequence at the N terminus, followed by a nonrepeated
A domain with two IgG-like folds dividing the A domain into
N1, N2, and N3 subdomains, a tandemly repeated domain at
the C terminus (and at the N terminus for SpsO), and a C-ter-
minal LPXTG anchor motif (Table 3). Of note, a TYTFT
DYVD motif or variant, important for the “dock, lock, and
latch” ligand-binding mechanism (35), was found in SpsD,
SpsL, and SpsO, and putative latching sequences were also
identified (Table 3). Further, putative Fn-binding motifs with
weak homology to FnbpA-10 of FnbpA in S. aureus (41) were
detected in the repeat region of SpsL (24% identity in pairwise
alignments for SpsL1 to SpsL6 and 21% for SpsL7). No ho-
mology to Fn-binding motifs of FnbpA was detected in the
repeat regions of SpsD and SpsO. The genes encoding SpsD,
SpsL, and SpsO have distinct locations in the S. pseudinterme-
dius ED99 genome. While spsD is located in a conserved re-
gion of the genome, spsL is in the oriC environ (50) (Fig. 2),
and spsO is located adjacent to two putative transposases,
suggesting that the locus may have been acquired by hori-
zontal gene transfer. Consistent with this observation, the
spsO gene was detected in only 7 of 20 S. pseudintermedius
strains examined, which represented several distinct clonal
lineages (Fig. 2).
S. pseudintermedius ED99 encodes two putative S. aureus
staphylococcal protein A (SpA) orthologues. S. pseudinterme-
dius ED99 has two predicted orthologues of S. aureus staphy-
lococcal protein A (SpA) (SpsP and SpsQ) which are encoded
adjacent to each other in the oriC environ of the genome (Fig.
2). The genes encode proteins with amino acid identity of 73%,
each with a predicted N-terminal signal sequence of 33 aa,
followed by a repeat region consisting of three and four pre-
dicted IgG-binding domains in SpsP and SpsQ, respectively
(Fig. 3). Each IgG-binding domain of SpsP comprises 55 aa,
with 78% to 89% identity between domains, whereas the four
IgG-binding domains of SpsQ vary from 59 aa for the first and
second, to 55 aa for the third, and 52 aa for the fourth domain
and have between 59% to 86% protein sequence identity in
any pairwise alignment. The repeated IgG-binding domains
are well conserved between SpsP and SpsQ, with 67% to 90%
sequence identity in pairwise alignments. On the C-terminal
side of the IgG-binding domains, SpsP and SpsQ contain a
predicted X region (Fig. 3). For SpsP, this region has 63%
overall sequence similarity to region X of S. aureus Newman
SpA, and for SpsQ the region consists of a 77-aa-long repeat
sequence (Xr) and a constant region (Xc) with 70% similarity
to the X region of S. aureus SpA. The Xr repeat region of SpsQ
was recently used to develop a typing method analogous to the
spa typing technique widely employed for epidemiological
analysis of S. aureus (30, 43).
Distribution of genes encoding CWA proteins among the S.
intermedius group. In order to investigate the distribution of
the putative CWA proteins identified in the S. pseudinterme-
dius ED99 genome among other S. pseudintermedius clinical
isolates, closely related species of the S. intermedius group
(SIG), and S. aureus, Southern blot analysis and PCR ampli-
fication were performed. A total of 20 S. pseudintermedius
strains representing the genetic diversity within the species,
members of the closely related S. delphini and S. intermedius
species, and a representative S. aureus isolate were screened
for the presence of the putative CWA protein-encoding genes
by Southern blot analysis (spsA to spsO) (Fig. 2). For the S.
aureus spa orthologues spsP and spsQ, PCR amplification was
employed as the genes share 70% nucleotide identity, which
precluded design of gene-specific probes for Southern blot
analysis. For similar reasons, the primers designed for PCR
amplification were located upstream of spsP (primer spsP-F),
in the nonrepeated region of spsP (primer spsP-R), in the
unique region between spsP and spsQ (primer spsQ-F), and in
a region unique for spsQ (primer spsQ-R) (Fig. 2). In addition,
PCR was used to screen for spsR. Of the 18 genes examined, 14
were found in all S. pseudintermedius strains investigated. The
remaining four genes (spsF, spsO, and the S. aureus spa ortho-
logues spsP and spsQ) were present in 6 to 11 of the 20 S.
pseudintermedius strains, depending on the gene. Furthermore,
homologs of 9 of the 18 genes were detected in S. delphini, 7
were found in S. intermedius, and 10 genes were exclusive to S.
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FIG. 2. Genome location and distribution of genes encoding CWA proteins. (A) Genome map of S. pseudintermedius ED99 indicating the
genomic location of each gene. (B) Distribution of the genes encoding putative CWA proteins among 20 S. pseudintermedius strains, represen-
tatives of the closely related S. delphini and S. intermedius, and other staphylococcal species associated with animal skin disease. The diversity of
strains is indicated by a phylogenetic tree constructed using the neighbor-joining method, with bootstrap values over 60 indicated; a blue square
denotes presence of a gene, and an empty square indicates its absence, based on Southern blot analysis (for spsA to spsO) or PCR amplification
(for spsP, spsQ, and spsR).
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pseudintermedius (Fig. 2). None of the genes encoding putative
CWA proteins was detected by Southern blotting or PCR anal-
ysis of S. aureus (data not shown). It cannot be excluded that
DNA sequence variation in PCR primer annealing sites for
spsP, spsQ, and spsR could contribute to the lack of gene
detection for some strains. Of note, five of seven genes con-
served in all S. pseudintermedius strains but not found in S.
delphini or S. intermedius were located in the oriC environ (Fig.
2). The oriC environ represents 250 kb around the origin of
replication in staphylococcal genomes and is typically the only
region of the genome which does not demonstrate synteny
between different staphylococcal species (50). Our data are
consistent with a role for the oriC environ in the speciation of
S. pseudintermedius and imply that the oriC-encoded CWA
proteins may have a function which is specific for the niche
occupied by S. pseudintermedius. An understanding of the dis-
tribution of genes encoding CWA proteins among S. pseudin-
termedius strains is important because CWA proteins made by
FIG. 3. Schematic representation of predicted CWA proteins encoded in the S. pseudintermedius ED99 genome. The predicted length in amino
acids of each protein is indicated; typical MSCRAMM features are shown as appropriate with signal sequence (red), the A domain with IgG-like
folds (labeled), repeat regions (blue), and a cell wall-anchoring LPX(TSA)/(GANS) motif (black). For SpsP and SpsQ (S. aureus SpA orthologues),
the repeated IgG-binding domains (blue) and X repeat regions (Xr; gray) are also indicated. All organisms belong to Staphylococcus species unless
otherwise noted. ORF, open reading frame.
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all strains could represent novel targets for broadly effective
therapeutics.
Determination of the surface proteome of S. pseudinterme-
dius ED99. Genome sequence interrogation for motifs charac-
teristic of genes encoding cell envelope-associated proteins
often results in identification of only a proportion of surface-
presented proteins. In order to identify the complement of
proteins presented on the surface of S. pseudintermedius in
vitro, we carried out surface proteome identification during
early, mid-, and late exponential phases of growth. Manual
inspection of the MS/MS spectrum was carried out for a total
of 917 protein hits, representing 140 unique proteins. To be
considered a positive result, protein identification required at
least one protein hit above stringent cutoff values for two of the
three technical replicates in at least one biological replicate. As
a result of the stringent filtering conditions applied to protein
identification, all proteins positively identified, except one, had
two or more peptides detected with a MOWSE score superior
or equal to 50. In total, 60 surface-localized proteins were
identified by proteomic analysis of S. pseudintermedius ED99 in
one or several growth phases tested (Table 4). According to
the functional annotation and additional tests performed to
predict subcellular localization, 10 of the proteins were pre-
dicted to be associated with the cell surface, and 7 were pre-
dicted to be secreted into the extracellular milieu (Table 4). Of
the 18 putative CWA proteins predicted in the genome, 6 were
identified in one or more phases, namely SpsD, SpsK, SpsL,
SpsN, SpsO, and SpsQ, suggesting that the other 12 predicted
CWA proteins were either not expressed under the conditions
tested, were present in quantities below the threshold of de-
tection of the LC-ESI-MS/MS technique, or were masked by
their location in the cell envelope.
Of the 60 proteins, 11 were detected in early exponential
phase, including all six surface proteome-detected CWA pro-
teins with the exception of SpsK, two putative secreted anti-
gens, a protein with homology to the extracellular adherence
protein (Eap) of S. aureus, and three cytoplasmic proteins
(large subunit [LSU] ribosomal protein L7/L12, NAD-depen-
dent glyceraldehyde-3-phosphate dehydrogenase [GAPDH],
and transcription elongation factor Tu). Most of the proteins
identified in early exponential phase were also found in both
mid- and late exponential phases, with the exception of SpsD,
Eap, and one of the two secretory antigens.
The majority of proteins identified (n
 50) were detected in
mid-exponential phase, of which 25 were specific for this
phase. Of note, 40 of the proteins recognized on the S. pseud-
intermedius surface in mid-exponential phase were predicted to
be intracellular proteins. In addition, five of the six predicted
CWA proteins (SpsD, SpsK, SpsL, SpsN, and SpsQ), the ATP
synthase alpha-chain, a triosephosphate isomerase, and a pu-
tative serine protease (HtrA) were identified on the cell sur-
face during mid-exponential phase.
During late exponential phase, a smaller number of proteins
was identified, with 33 proteins identified in total, of which only
7 were specific for this phase: arginine deiminase, dihydroli-
poamide dehydrogenase, pyruvate formate-lyase, a putative
lipoprotein, two putative general stress proteins, and a tran-
scriptional regulator of the LytR family (Table 4). The identi-
fication of intracellular proteins on the cell surface is not un-
expected, and numerous studies of S. aureus have reported a
similar phenomenon (10, 16, 46, 53, 58). In some cases, alter-
native functions associated with the cell surface have been
described for cytoplasmic proteins, including GAPDH (26, 52),
enolase (4, 23), transcription elongation factors (1, 24), and
chaperone proteins GroES and DnaK (20, 57). In addition,
ribosomal proteins are commonly identified on the bacterial
cell surface and can exhibit a high degree of immunogenicity
for humans (25, 48).
Overall, these data represent the first identification of the
TABLE 2. Repeat regions of S. pseudintermedius CWA proteins
CWA protein No. ofrepeats
Repeat
length (aa)
Pairwise
identity (%) Characteristic(s)
SpsD 5 21 90–100
SpsF 9 86 72–100
9 15 73–100
SpsI 3 112 77–96 B-repeat family
5 14 100
SpsJ 6 80 65–92
3 18–20 85–100
9 46 80–100
61 12–20 42–100 SDSD and STS rich
SpsL 7 37 91–100
SpsO 96 12 91–100 Serine rich
4 26 76–96
SpsP 3 55 78–89 IgG binding
SpsQ 4 52–59 59–86 IgG binding
TABLE 3. Characteristics of the predicted CWA proteins SpsD, SpsL, and SpsO of S. pseudintermedius ED99
Protein Length(aa)
Mass
(kDa)a
Signal peptide
length (aa) LPXTG motif
Position of
IgG-like
fold(s)b
TYTFTDYVD-like motif
(position)b
Putative latching
sequence (position)b
Position of repeat
region(s) (aa)
Copy
no.
repeats
SpsD 1,031 115 36 LPDTG 167–320 RYRFMDYVN (267–275) NNASGEG (491–497) 867–959 5
322–519
SpsL 930 103 38 LPKTG 220–363 VYTFKDYVN (298–306) NSASGSG (502–508) 543–818 7
364–531
SpsO 1,846 198 44 LPNTG 339–492 TYTFTDYVD (424–432) DKSTALG (635–641) 661–1800 96
487–659 97–216c 4c
a Predicted approximate molecular mass.
b Motifs are within the A domain. Positions are amino acid numbering.
c N-terminal repeat.
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complete surface proteome for a strain of S. pseudintermedius.
Although some of the proteins were in common with other
studies of surface proteomes of Gram-positive bacteria, 27 S.
pseudintermedius proteins were identified for which homologs
had not been previously identified on the surface of other
bacterial species. Ribosomal proteins represented 16 proteins,
and 9 of the 11 other proteins identified were predicted to be
involved in host-pathogen interactions, including putative cell
wall-anchored proteins, secreted antigens, and a putative lipo-
protein (Table 4). These data highlight the complementary
role that proteomics can play in identifying surface-presented
proteins which are not predicted from genome sequence anal-
ysis. In particular, our understanding of the function of intra-
cellular proteins when presented on the cell surface is very
limited, and the possibility that such proteins may represent
valid therapeutic targets has not been well examined to date.
S. pseudintermedius CWA proteins mediate binding to extra-
cellular matrix proteins. In order to investigate the molecular
basis of S. pseudintermedius adherence to the extracellular ma-
trix, we selected the only two CWA proteins (SpsD and SpsL)
which were detected in the surface proteome and encoded by
all strains and which had each of the CWA characteristics
searched for, including a signal sequence at the N terminus, a
nonrepeated A domain with two IgG-like folds, a tandemly
repeated domain at the C terminus, and a C-terminal LPXTG
anchor motif, and investigated their capacity to mediate ad-
herence to ECM proteins. L. lactis expressing SpsD and SpsL
and L. lactis carrying the vector pOri23 alone were tested for
their ability to adhere to human fibronectin. L. lactis expressing
SpsD and SpsL demonstrated adherence to human fibronectin
in a dose-dependent manner (Fig. 4C). Of note, SpsD and
SpsL contain 32% and 27% amino acid identity, respectively,
with fibronectin-binding protein B (FnbpB) encoded by S. au-
reus strain Mu50. Further, SpsL contains seven repeats with
weak homology to repeats of FnbpA involved in adherence to
fibronectin (41), suggesting that a related mechanism of bind-
ing to fibronectin may exist for SpsL. In contrast, SpsD did not
contain sequence homology with the fibronectin-binding re-
gion of FnbpA, suggesting a distinct mechanism of interaction
with fibronectin for SpsD.
Previous studies have reported considerable variation in the
sequence of fibrinogen from different vertebrate species, im-
plying a requirement for host specialization of fibrinogen-bind-
ing proteins made by bacteria colonizing different host species
(28). We tested the capacity of CWA proteins to mediate
binding of L. lactis to fibrinogen of canine, human, feline,
avian, equine, and bovine origin. Both SpsD and SpsL medi-
ated adherence of L. lactis to canine fibrinogen with high
affinity (P 	 0.01) (Fig. 4A and B). In addition, L. lactis ex-
pressing SpsD adhered to bovine fibrinogen with similar affin-
ity but adhered less well to human, equine, and avian fibrino-
gens (P 	 0.01) (Fig. 4A). We speculate that the region of
fibrinogen that is involved in binding to SpsD is conserved in
canine and bovine hosts, leading to a similar high-affinity in-
teraction. In contrast, in addition to canine fibrinogen, SpsL
mediated strong adherence to equine and avian fibrinogens
(P 	 0.01) but demonstrated weak or no adherence to fibrin-
ogens of human and bovine origins. These data imply that
SpsD and SpsL have different affinities for fibrinogens from
different host species which could involve different regions of
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the host ligand. The data also suggest that S. pseudintermedius
has evolved host-specialized CWA proteins which mediate ef-
ficient binding to canine fibrinogen. Further molecular analysis
is required to identify the bacterial protein and host ligand
domains involved in the interaction.
Finally, SpsD mediated robust adherence of L. lactis to re-
combinant mouse cytokeratin 10 in solid-phase assays (P 	
0.001), but SpsL demonstrated only weak adherence (Fig. 4D).
The interaction of S. aureus with cytokeratin 10, a major sub-
stituent of human skin, is mediated by at least two CWA-
associated proteins, including ClfB and IsdA (5, 54), and is
considered to be important for S. aureus nasal colonization
(56). The identification of a cytokeratin 10-binding surface
protein of S. pseudintermedius suggests that such an interaction
may also be important for canine host colonization. SpsD ap-
pears to be a promiscuous binding protein with the capacity to
bind to at least three host ligands, including fibrinogen, fi-
bronectin, and cytokeratin 10, in a dose-dependent and satu-
rable manner. Of note, the marked elevation of binding of S.
pseudintermedius strain ED99 to fibrinogen and cytokeratin 10
in the exponential phase of growth correlates with the identi-
fication of SpsD in the surface proteome of ED99 during the
early and mid-exponential phases of growth and its absence at
the late exponential time point (Fig. 1 and Table 4).
Several CWA proteins made by S. aureus have been shown
to interact with multiple protein ligands. For example, FnbpA
mediates binding to fibronectin, fibrinogen, and elastin (27, 39,
55), and ClfB mediates binding to fibrinogen and cytokeratin 10
(31, 54). The existence of tandem IgG-related sequences in SpsD
and SpsL suggests that a ligand-binding mechanism analogous to
that of other microbial surface components recognizing adhesive
matrix molecules (MSCRAMMs) may exist (14, 35).
S. pseudintermedius CWA proteins SpsD and SpsL are pro-
duced during colonization or infection of dogs. The surface
proteome of S. pseudintermedius during growth under nutrient-
replete conditions in vitro may differ considerably from that
FIG. 4. Adherence of L. lactis expressing specified CWA proteins to immobilized ligands. (A and B) Plates were coated with doubling dilutions of
fibrinogen (Fg) of human, bovine, canine, equine, or avian origin or with bovine serum albumin (BSA), as indicated in the legend of panel B, and
incubated withL. lactis expressing SpsD or SpsL.L. lactis with empty expression vector pOri23 incubated with immobilized canine fibrinogen was included
as a negative control. (C and D) For panel C plates were coated with doubling dilutions of bovine fibronectin and incubated with L. lactis expressing SpsD
or SpsL, as indicated on panel D. L. lactis with empty expression vector pOri23 incubated with immobilized bovine fibronectin was included as a negative
control. For panel D, plates were coated with doubling dilutions of recombinant mouse cytokeratin 10 and incubated with L. lactis expressing SpsD or
SpsL. L. lactis with empty expression vector pOri23 incubated with immobilized recombinant mouse cytokeratin 10 was included as a negative control.
Absorbance was measured at 590 nm, and results are expressed as mean values of triplicate samples. Error bars indicate standard deviation. S. aureus
strain SH1000, strain Newman, and an isogenic derivative of strain Newman deficient in ClfA production were used as controls (data not shown).
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during infection. In vivo expression and host immune recogni-
tion are important characteristics of candidate protective an-
tigens. Reactivity of recombinant A domains from SpsD and
SpsL with canine serum obtained from bacterial pyoderma
cases was examined by Western blot analysis. Both recombi-
nant SpsD (rSpsD) and rSpsL, but not the negative-control
recombinant staphylococcal enterotoxin I (rSEI) of S. aureus,
bound to IgG present in the canine serum (Fig. 5). These data
indicate that IgG specific for SpsD and SpsL is present in sera
from dogs with bacterial pyoderma, indicating that both pro-
teins are produced during either S. pseudintermedius coloniza-
tion or infection, are recognized by the host, and induce a
humoral immune response.
Concluding comments. Overall, these results provide impor-
tant new information relating to the adhesive proteins pre-
sented on the surface of S. pseudintermedius. Stranger-Jones et
al. screened the genome of S. aureus for all genes predicted to
encode CWA proteins and immunized mice with each protein
to determine their capacity to protect against lethal or invasive
infection (49). Several of the proteins were combined into a
multiple protein vaccine which induced high levels of protec-
tion against S. aureus invasive disease of mice (49), stimulating
renewed optimism for a vaccine for the prevention of human S.
aureus infections. In addition to their potential use as vaccine
components, CWA proteins are being examined as passive
immunotherapeutic targets (32, 38). In particular, the major
fibrinogen-binding protein, ClfA, has been the focus of anti-
body-based therapeutics which have reached the phase III trial
stage, albeit unsuccessfully (32). Recently, we have published
the structure for ClfA binding to its major ligand fibrinogen,
resulting in the design of peptides which block ClfA function
but do not interfere with fibrinogen binding to platelets, an
essential step in platelet aggregation (14). These peptides are
currently under investigation as potential therapeutic agents
for treating staphylococcal disease (14). Overall, we report the
genome-scale prediction and proteomic identification of the
complement of S. pseudintermedius surface proteins and de-
scribe novel host-pathogen interactions likely to be important
in pathogenesis. The data presented here represent an impor-
tant step toward the rational design of preventive or therapeu-
tic approaches for controlling bacterial canine pyoderma.
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